Lymphoma Hub Satellite Symposium 2019 | Chemo-free approaches in MCL - Professor Simon Rule
Professor Simon Rule discussed the novel chemotherapy-free treatment approaches in MCL during the Lymphoma Hub Satellite Symposium at 15-ICML.
Results from the OAsis phase I/II trial on ibrutinib, venetoclax plus obinutuzumab in patients with newly diagnosed mantle cell lymphoma
During the 2020 European Hematology Association (EHA) Annual Congress, Steven Le Gouill presented data from...
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox